Back to mobile site

Teva Pharmaceutical (TEVA) Tops Q1 EPS by 2c

May 2, 2013 7:02 AM EDT Send to a Friend
Teva Pharmaceutical (NYSE: TEVA) reported Q1 EPS of $1.12, $0.02 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login